A previous study showed that GSTM1 induces tumor resistance by hydrolyzing tumor chemotherapy drugs or activating anti-apoptotic pathways, [26] and it was shown to be a negative regulator of apoptosis-related signaling cascades [22]. Here, GSTM1 is linked to neoplasm.